Onkure Therapeutics Inc (OKUR)

Currency in USD
2.290
+0.010(+0.44%)
Real-time Data·
OKUR Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
OKUR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.2702.415
52 wk Range
1.70019.999
Key Statistics
Prev. Close
2.28
Open
2.38
Day's Range
2.27-2.415
52 wk Range
1.7-19.999
Volume
39.8K
Average Volume (3m)
157.51K
1-Year Change
-84.8%
Book Value / Share
6.75
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
OKUR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
29.800
Upside
+1,201.31%
Members' Sentiments
Bearish
Bullish
ProTips
3 analysts have revised their earnings upwards for the upcoming period

Onkure Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Onkure Therapeutics Inc Company Profile

OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3 kinase alpha harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company is headquartered in Boulder, Colorado.

Compare OKUR to Peers and Sector

Metrics to compare
OKUR
Peers
Sector
Relationship
P/E Ratio
−0.5x−4.5x−0.5x
PEG Ratio
0.000.000.00
Price/Book
0.3x2.1x2.6x
Price / LTM Sales
-9.4x3.2x
Upside (Analyst Target)
-192.0%41.2%
Fair Value Upside
Unlock11.6%6.2%Unlock

Analyst Ratings

6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 29.800
(+1,201.31% Upside)

Earnings

Latest Release
May 06, 2025
EPS / Forecast
-1.19 / -0.5633
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

OKUR Income Statement

People Also Watch

230.25
LEU
-3.82%
3.04
INMB
+4.30%
7.153
AMPX
-13.72%
23.66
OUST
-8.75%
12.56
STOK
-1.95%

FAQ

What Stock Exchange Does Onkure Therapeutics Trade On?

Onkure Therapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Onkure Therapeutics?

The stock symbol for Onkure Therapeutics is "OKUR."

What Is the Onkure Therapeutics Market Cap?

As of today, Onkure Therapeutics market cap is 30.94M.

What Is Onkure Therapeutics's Earnings Per Share (TTM)?

The Onkure Therapeutics EPS (TTM) is -8.78.

From a Technical Analysis Perspective, Is OKUR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Onkure Therapeutics Stock Split?

Onkure Therapeutics has split 1 times.

How Many Employees Does Onkure Therapeutics Have?

Onkure Therapeutics has 46 employees.

What is the current trading status of Onkure Therapeutics (OKUR)?

As of 29 Jul 2025, Onkure Therapeutics (OKUR) is trading at a price of 2.29, with a previous close of 2.28. The stock has fluctuated within a day range of 2.27 to 2.42, while its 52-week range spans from 1.70 to 20.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.